Center-Authored Papers

Filters: Author is Kibel, Adam S  [Clear All Filters]
2017
Brunner C, Davies NM, Martin RM, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles G et al..  2017.  Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study.. International journal of cancer. 140(1):75-85. Abstract
Gore JL, du Plessis M, Santiago-Jiménez M, Yousefi K, Thompson DJS, Karsh L, Lane BR, Franks M, Chen DYT, Bandyk M et al..  2017.  Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.. Cancer. Abstract
2016
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ et al..  2016.  PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.. Journal of medical genetics. Abstract
Kar SP, Beesley J, Al Olama AA, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ et al..  2016.  Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.. Cancer discovery. 6(9):1052-1067. Abstract
Taylor AE, Martin RM, Geybels MS, Stanford JL, Shui I, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S et al..  2016.  Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis.. International journal of cancer. Abstract
Bonilla C, Lewis SJ, Rowlands M-A, Gaunt TR, Smith GD, Gunnell D, Palmer T, Donovan JL, Hamdy FC, Neal DE et al..  2016.  Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.. International journal of cancer. 139(7):1520-1533. Abstract
Antonarakis ES, Kibel AS, Yu EY, Karsh LI, Elfiky A, Shore ND, Vogelzang NJ, Corman JM, Millard FE, Maher JC et al..  2016.  Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically-Recurrent Prostate Cancer: A Phase II Randomized Trial.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG, Wiklund F, Grönberg H, Haiman CA, Schleutker J et al..  2016.  Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.. British journal of cancer. Abstract
Bull CJ, Bonilla C, Holly JM, Perks CM, Davies N, Haycock P, Yu OHY, Richards BJ, Eeles R, Easton D et al..  2016.  Blood lipids and prostate cancer: a Mendelian randomization analysis.. Cancer medicine. 5(6):1125-1136. Abstract
Lin H-Y, Chen D-T, Huang P-Y, Liu Y-H, Ochoa A, Zabaleta J, Mercante DE, Fang Z, Sellers TA, Pow-Sang JM et al..  2016.  SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns.. Bioinformatics (Oxford, England). Abstract
Khankari NK, Murff HJ, Zeng C, Wen W, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K et al..  2016.  Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium.. British journal of cancer. Abstract
Gusev A, Shi H, Kichaev G, Pomerantz M, Li F, Long HW, Ingles SA, Kittles RA, Strom SS, Rybicki BA et al..  2016.  Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation.. Nature communications. 7:10979. Abstract
Bonilla C, Lewis SJ, Martin RM, Donovan JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA et al..  2016.  Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort.. BMC medicine. 14(1):66. Abstract
2015
Davies NM, Gaunt TR, Lewis SJ, Holly J, Donovan JL, Hamdy FC, Kemp JP, Eeles R, Easton D, Kote-Jarai Z et al..  2015.  The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium.. Cancer causes & control : CCC. Abstract
Al Olama AA, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S et al..  2015.  Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.. Human molecular genetics. 24(19):5589-5602. Abstract
Szulkin R, Karlsson R, Whitington T, Aly M, Gronberg H, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Benlloch S et al..  2015.  Genome-wide association study of prostate cancer-specific survival.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(11):1796-1800. Abstract
Szulkin R, Whitington T, Eklund M, Aly M, Eeles RA, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K et al..  2015.  Prediction of individual genetic risk to prostate cancer using a polygenic score.. The Prostate. Abstract
Crawford DE, Petrylak DP, Higano CS, Kibel AS, Kantoff PW, Small EJ, Shore ND, Ferrari A.  2015.  Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer.. The Canadian journal of urology. 22(6):8048-55. Abstract
Stegeman S, Amankwah E, Klein K, O'Mara TA, Kim D, Lin H-Y, Permuth-Wey J, Sellers TA, Srinivasan S, Eeles R et al..  2015.  A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer.. Cancer discovery. 5(4):368-79. Abstract
2014
Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E et al..  2014.  A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.. Nature genetics. 46(10):1103-9. Abstract
Han Y, Signorello LB, Strom SS, Kittles RA, Rybicki BA, Stanford JL, Goodman PJ, Berndt SI, Carpten J, Casey G et al..  2014.  Generalizability of established prostate cancer risk variants in men of African ancestry.. International journal of cancer. Journal international du cancer. Abstract
Saunders EJ, Dadaev T, Leongamornlert DA, Jugurnauth-Little S, Tymrakiewicz M, Wiklund F, Al Olama AA, Benlloch S, Neal DE, Hamdy FC et al..  2014.  Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer.. PLoS genetics. 10(2):e1004129. Abstract
Wei JT, Feng Z, Partin AW, Brown E, Thompson I, Sokoll L, Chan DW, Lotan Y, Kibel AS, Busby EJ et al..  2014.  Can urinary PCA3 supplement PSA in the early detection of prostate cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(36):4066-72. Abstract
2013
Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurnauth-Little S, Ross-Adams H, Al Olama AA, Benlloch S, Halim S et al..  2013.  Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.. Human molecular genetics. Abstract
Patterson RE, Colditz GA, Hu FB, Schmitz KH, Ahima RS, Brownson RC, Carson KR, Chavarro JE, Chodosh LA, Gehlert S et al..  2013.  The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) Initiative: Rationale and Design.. Cancer causes & control : CCC. Abstract